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 Study Design.  Subgroup analysis of the lumbar spinal stenosis 
(LSS) without degenerative spondylolisthesis diagnostic cohort of 
the Spine Patient Outcomes Research Trial multicenter randomized 
clinical trial with a concurrent observational cohort. 
 Objective.  To determine if sedimentation sign on magnetic 
resonance image can help with LSS treatment decisions. 
 Summary of Background Data.  LSS is one of the most common 
reasons for surgery in the US elderly, but there is a dearth of reliable 
diagnostic tools that give a clear indication for surgery. Recent 
studies have suggested that positive sedimentation sign on magnetic 
resonance image may be a possible prognostic indicator. 
 Methods.  All patients with LSS in both the randomized and 
observational cohorts had imaging-confi rmed stenosis, were surgical 
candidates, and had neurogenic claudication for at least 12 weeks 
prior to enrollment. Patients were categorized as “mild,” “moderate,” 
or “severe” according to stenosis severity. Of the 654 patients with 
LSS enrolled in Spine Patient Outcomes Research Trial, complete 
T2-weighted axial and sagittal digitized images of 115 patients 
were available for retrospective review. An independent orthopedic 
spine surgeon evaluated these deidentifi ed Digital Imaging and 
Communications in Medicine fi les for the sedimentation sign. 
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 First described by Verbiest in 1947, 
1 lumbar spinal ste-
nosis (LSS) has become one of the most common surgi-
cally treated ailments affecting our aging population. 2 , 3 
Despite this fact, there have yet to be clear treatment indica-
tions for this disease, partly due to a lack of reliable diag-
nostic tools. 4–10 In addition to clinical diagnostic tests, 11–15 
cross-sectional spinal canal narrowing has become a com-
monly accepted imaging criteria of LSS, 16 , 17 yet, several stud-
ies have shown that there can be little correlation between 
anatomical narrowing, clinical symptoms, and treatment 
outcomes.  5,11,7,8,15  , 17–22 
 Recently, Barz  et al 23 introduced the sedimentation sign on 
magnetic resonance image (MRI) as a possible aid in decision 
making for LSS. Normally, in the supine position the lum-
bar nerve roots should settle to the posterior spinal canal due 
to gravity and the absence of constrictive force. A positive 
sedimentation sign, however, is evident when a patient lying 
supine has the absence of posterior nerve root settling. 1 , 14 , 23 , 24 
A previous study by Barz  et al 23 demonstrated the ability of 
the sedimentation sign to discriminate between known cases 
of symptomatic central LSS and controls with nonspecifi c 
low back pain. An observational follow-up study by the same 
 Results.  Sixty-six percent (76/115) of patients were found to have 
a positive sedimentation sign. Those with a positive sedimentation 
sign were more likely to have stenosis at L2–L3 (33%  vs . 10%  P  = 
0.016) or L3–L4 76%  vs . 51%,  P  = 0.012), and to have severe (72% 
 vs . 33%,  P  < 0.0001) central stenosis (93%  vs . 67%  P  < 0.001) at 2 
or more concurrent levels (57%  vs . 18%,  P  = 0.01). In multivariate 
models, the surgical treatment effect was signifi cantly larger in the 
positive sedimentation sign group for Oswestry Disability Index 
( − 16  vs .  − 7;  P  = 0.02). 
 Conclusion.  A positive sedimentation sign was associated with a 
small but signifi cantly greater surgical treatment effect for Oswestry 
Disability Index in patients with symptomatic LSS, after adjusting for 
other demographic and imaging features. These fi ndings suggest that 
positive sedimentation sign may potentially be a useful adjunct to 
help guide an informed treatment choice regarding surgery for LSS. 
 Key words:  lumbar spinal stenosis ,  sedimentation sign ,  MRI , 
 shared decision making ,  surgical treatment . 
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group showed that, in patients treated with decompression 
surgery, the sign does not seem to predict surgical outcome, 
whereas in nonoperatively treated patients, a positive sign is 
associated with more limited improvement. 25 This evidence 
indicates that the sedimentation sign may provide information 
about prognosis in patients who do not proceed to surgery 
and/or help to identify patients more likely to benefi t from 
surgery. However, to date no studies have provided unbiased 
estimates of the relationship between a positive sedimentation 
sign and treatment outcomes in patients with LSS. 
 The Spine Patient Outcomes Research Trial (SPORT), 
a multicenter randomized clinical trial with a concurrent 
observational cohort, demonstrated better outcomes for 
patients with LSS  treated surgically than those treated non-
operatively; however, 2 years after surgery only 63% report 
major symptomatic improvement, whereas almost 30% 
of patients treated nonoperatively report a similar level of 
improvement. 26 Improved ability to identify patients more or 
less likely to benefi t from surgical intervention would be an 
important aid to clinical decision making. To this end, we 
performed a subgroup analysis on the SPORT LSS cohort; 
we used baseline MR images from patients with LSS enrolled 
in SPORT to evaluate the association between a positive 
sedimentation sign and surgical treatment effect, defi ned as 
the difference between the average change in the surgical 
group minus the average change in the nonoperative group. 
In consideration of the observational evidence available, we 
hypothesized that a positive sedimentation sign may predict 
poorer outcomes with nonoperative treatment and/or rela-
tively improved outcomes with surgery, thus demonstrating a 
greater surgical treatment effect. Our analysis focuses on the 
difference in outcome between the surgical group compared 
with the nonoperative group, which is the surgical treatment 
effect, because it is the key parameter in understanding the 
relative benefi t of surgery, which in turn is the crucial piece 
of information in decision making for a patient weighing the 
choice between those 2 options. 
 MATERIALS AND METHODS 
 SPORT was a multicenter investigation that obtained pro-
spective data from 13 spine clinics contained in 11 states. All 
included patients had to be surgical candidates, have a history 
of neurogenic claudication for a period of at least 12 weeks, 
and have cross-sectional imaging demonstrating stenosis. Ste-
nosis severity was categorized as mild: dural area compromise 
of  1/3 or more expected; moderate: dural area compromise 
between 1/3 and 2/3 expected; and severe: a dural area com-
promise of more than 2/3 expected. 27 Patients with lumbar 
instability and degenerative spondylolisthesis were excluded 
from this cohort. Standard posterior decompression laminec-
tomy comprised surgical management. 28 Nonoperative inter-
ventions included prescribed physical activity, counseling, 
steroid epidural injections, opioids, and nonsteroidal anti-
infl ammatory drugs. 28 , 29 
 The study’s primary outcome measures included the 
36-Item Short Form General Health Survey (SF-36) Physical 
Function and Bodily Pain scales, 30 , 31 the stenosis bothersome-
ness index (SBI), 32 , 33 and the modifi ed Oswestry Disability 
Index (ODI). 34 The SF-36 is scored on a scale of 0 to 100 with 
larger scores indicating better function and less pain. The SBI 
scores range from 0 to 24 with lower scores indicating less 
severe symptoms, and the ODI is scored on a scale of 0 to 100 
and similarly, lower scores indicate a better outcome. 
 A total of 654 patients with LSS were enrolled in 
SPORT. 26 , 27 Of these patients, complete T2-weighted axial 
and sagittal digitized images of 115 patients were available 
for retrospective review, which were deidentifi ed and elec-
tronically uploaded as Digital Imaging and Communica-
tions in Medicine fi les. 27 These images were provided to an 
independent orthopedic spine surgeon on individual com-
pact discs and eFilm Light software was used to view these 
images (Merge Technologies, Milwaukee, WI). Each patient’s 
T2-weighted axial images were evaluated for the presence of 
a positive sedimentation sign. Following the original descrip-
tion by Barz  et al , 23 “a positive sedimentation sign is defi ned 
 Figure 1.  Left: negative sedimentation sign exam-
ple (normal) and right: positive sedimentation sign 
(abnormal). Reproduced with permission from the 
study by Barz  et al . 23 
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 TABLE 1.  Baseline Demographic Characteristics, 
Comorbidities, and Health Status 
Measures of the Patients According to 
Whether the Patient Had Nerve Root 
Sedimentation Sign 
Characteristic
Sedimentation Sign
Negative 
(n  = 39)*
Positive 
(n  = 76)*  P 
Age, mean (SD), yr 61.4 (11.1) 65.7 (12.9) 0.075
Females, no. (%) 19 (49) 32 (42) 0.63
Ethnicity, non-Hispanic, no. 
(%)† 34 (87) 70 (92) 0.61
Race, Caucasian,  no. (%)† 29 (74) 63 (83) 0.40
Education, at least some 
college, no. (%) 28 (72) 42 (55) 0.13
Income, under $50,000 8 (21) 16 (21) 0.86
Married, no. (%) 27 (69) 50 (66) 0.87
Work status, no. (%) 0.41
 Full or part time 18 (46) 24 (32)
 Disabled 2 (5) 7 (9)
 Retired 16 (41) 35 (46)
 Other 3 ( 8) 10 (13)
Disability compensation, 
no. (%)‡ 3 (8) 3 (4) 0.68
BMI, mean (SD)§ 28.3 (4.3) 29.1 (5.5) 0.42
Smoker, no. (%) 8 (21) 10 (13) 0.45
Comorbidities, no. (%)
 Hypertension 14 (36) 40 (53) 0.13
 Diabetes 5 (13) 14 (18) 0.62
 Osteoporosis 8 (21) t4 (5) 0.027
 Heart problem 7 (18) 19 (25) 0.54
 Stomach problem 10 (26) 13 (17) 0.40
 Bowel or intestinal 
 problem 5 (13) 4 (5) 0.29
 Depression 5 (13) 10 (13) 0.81
 Joint problem 20 (51) 37 (49) 0.95
 Other¶ 13 (33) 27 (36) 0.98
Time since most recent 
episode  > 6 mo, no. (%) 23 (59) 36 (47) 0.33
SF-36 scores, mean (SD)
 BP 32.7 (18.6) 32.4 (18) 0.95
 PF 44.7 (26.4) 36.7 (22.6) 0.091
  PCS 51.4 (10.6) 49.5 (12.9) 0.44
  MCS 32.1 (8.5) 29.6 (9.3) 0.17
ODI** 42.9 (22.4) 38.9 (18.7) 0.32
Stenosis frequency index 
(0–24)†† 14.2 (6.6) 12.7 (6.3) 0.24
 TABLE 1.  ( Continued ) 
Characteristic
Sedimentation Sign
 P 
Negative 
(n  = 39)*
Positive 
(n  = 76)*
Stenosis bothersomeness 
index 13.7 (6.5) 13 (5.9) 0.57
Back pain bothersomeness 
index §§ 3.9 (1.9) 4.1 (1.7) 0.47
Leg pain bothersomeness 
index¶¶ 4.1 (1.8) 4.1 (1.6) 0.88
Patient very dissatisfi ed with 
symptoms, no. (%) 25 (64) 48 (63) 0.92
Patient’s self-assessed health 
trend, no. (%) 0.40
 Problem getting better 3 (8) 10 (13)
 Problem staying about the 
 same 10 (26) 24 (32)
 Problem getting worse 26 (67) 40 (53)
Treatment preference, 
no. (%) 0.55
 Preference for nonsurgical 
 treatment 14 (36) 35 (46)
 Not sure 12 (31) 18 (24)
 Preference for surgery 13 (33) 23 (30)
Neurogenic claudication, 
no. (%) 34 (87) 65 (86) 0.97
Pain on straight leg raising 
or femoral nerve tension 
sign, no. (%)
7 (18) 7 (9) 0.29
Dermatomal pain radiation, 
no. (%) 35 (90) 60 (79) 0.24
Any neurological defi cit, 
no. (%) 25 (64) 40 (53) 0.33
 Asymmetric depressed 
 refl exes 9 (23) 18 (24) 0.87
 Asymmetric decrease in 
 sensory refl exes 15 (38) 17 (22) 0.11
 Asymmetric motor 
 weakness 13 (33) 23 (30) 0.90
Stenosis levels, no. (%)
 L2–L3 4 (10) 25 (33) 0.016
 L3–L4 20 (51) 58 (76) 0.012
 L4–L5 35 (90) 71 (93) 0.74
 L5–S1 10 (26) 18 (24) 1
Stenotic levels (moderate/
severe) 0.01
 None 1 (3) 0 (0)
 1 20 (51) 19 (25)
 2 14 (36) 37 (49)
 3 + 4 (10) 20 (26)
( Continued ) ( Continued )
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categorical variables and  t tests for continuous variables. The 
primary analysis compared surgical and nonoperative treat-
ments using changes from baseline at each follow-up, with 
a mixed effects longitudinal regression model including a 
random individual effect to account for correlation between 
repeated measurements within individuals. Because of high 
rates of treatment crossover, analyses were based on treat-
ments actually received in the combined randomized and 
observational cohorts as described in the previous text. 26 , 28 
 To adjust for potential confounding, baseline variables 
that were signifi cantly different between the 2 subgroups 
(those with and without a positive sedimentation sign) were 
included as adjusting covariates in the models. In addition, 
age, sex, and baseline outcome scores (for SF-36, ODI, and 
SBI) were included in all longitudinal outcome models. Across 
the 4-year follow-up, overall comparisons of the area under 
the curve between these subgroups were made using a Wald 
test. Computations were done using SAS PROC MIXED pro-
cedure (SAS version 9.2 Windows XP Pro; SAS Institute Inc., 
Cary, NC). Statistical signifi cance was defi ned as  P  < 0.05 
based on a 2-sided hypothesis test with no adjustments made 
for multiple comparisons. 
 RESULTS 
 The 115 baseline MRIs were reviewed by an independent 
reader who was blinded to treatment group and outcome. 
Sixty-six percent (76/115) of patients were found to have a 
positive sedimentation sign.  Table 1 depicts the comparison of 
baseline demographics between the 2 subgroups demonstrat-
ing that individuals with a positive sedimentation sign were 
more likely to have stenosis at either L2–L3 (33%  vs . 10%, 
 P  = 0.016) or L3–L4 (76%  vs . 51%,  P  = 0.012), central 
stenosis (93%  vs . 67%,  P  < 0.001), severe stenosis (72%  vs . 
33%,  P  < 0.0001), and have 2 or more concurrent stenotic 
levels (57%  vs . 18%,  P  = 0.01). 
 Table 2 compares the surgical procedures and complica-
tions between the 2 groups. A total of 75 patients in this sub-
group analysis underwent surgery, 47 of 76 (62%) of those 
with a positive sedimentation sign and 28 of 39 (72%) of 
those with a negative sign. There were no statistically signifi -
cant differences in operative treatment or complication rates 
between the 2 subgroups. 
 The 4-year time-weighted average of outcome measures in 
the 2 subgroups is summarized in  Table 3 . In general, the sur-
gical treatment effect was larger in the positive sedimentation 
sign group for all outcomes. This was statistically signifi cant 
for ODI ( − 16  vs .  − 7;  P  = 0.02); SBI ( − 5.7  vs .  − 3.2;  P  = 
0.09), SF-36 bodily pain (15.4  vs . 11.5;  P  = 0.44), and SF-36 
physical function (17.7  vs . 15.1;  P  = 0.61) were not signifi -
cantly different. These analyses were controlled for age, sex, 
baseline outcome score, osteoporosis, stenosis level, stenosis 
location (central  vs . foraminal), and stenosis severity. 
 DISCUSSION 
 Determining the optimal treatment intervention for patients 
with symptomatic LSS can be diffi cult because the degree and 
location of anatomical narrowing may not correlate with 
 TABLE 1.  (Continued) 
Characteristic
Sedimentation Sign
Negative 
(n  = 39)*
Positive 
(n  = 76)*  P 
Stenosis locations, no. (%)
 Central 26 (67) 71 (93)  < 0.001
 Lateral recess 32 (82) 65 (86) 0.83
 Neuroforamen 12 (31) 19 (25) 0.66
Stenosis severity, no. (%)  < 0.001
 Mild 1 (3) 0 (0)
 Moderate 25 (64) 21 (28)
 Severe 13 (33) 55 (72)
Spinal instability 0 (0) 0 (0) …
Underwent surgery*** 28 (72) 47 (62) 0.39
 *Total 115 patients, who had MRI/information of nerve root sedimentation 
sign and had at least 1 follow-up through 4 yr, are in the current analysis. 
 †Race or ethnic group was self-assessed. Caucasians and African Americans 
could be either Hispanic or non-Hispanic. 
 ‡This category includes patients who were receiving or had applications 
pending for workers compensation, social security, or other compensation. 
 §The body mass index is the weight in kilograms divided by the square of 
the height in meters. 
 ¶Other denotes problems related to stroke, cancer, lung, fi bromyalgia, CFS, 
PTSD, alcohol, drug dependency, liver, kidney, blood vessel, nervous system, 
migraine, and anxiety. 
 The SF-36 scores range from 0 to 100, with higher score indicating less 
severe symptoms. 
 **The ODI ranges from 0 to 100, with lower scores indicating less severe 
symptoms. 
 ††The stenosis frequency index ranges from 0 to 24, with lower scores 
indicating less severe symptoms. 
 ‡‡The stenosis bothersomeness index ranges from 0 to 24, with lower scores 
indicating less severe symptoms. 
 §§The low back pain bothersomeness index ranges from 0 to 6, with lower 
scores indicating less severe symptoms. 
 ¶¶The leg pain bothersomeness index ranges from 0 to 6, with lower scores 
indicating less severe symptoms. 
  Spinal instability is defi ned as a change of more than 10º of angulation 
or more than 4 mm of translation of the vertebrae between fl exion and 
extension of the spine. 
 ***Patients who underwent surgery were classifi ed according to whether 
they underwent surgical treatment during the fi rst 4 yr of enrollment. 
 BMI indicates body mass index; BP, bodily pain; PF, physical functioning; 
PCS, physical component summary; MCS, mental component summary; 
ODI, Oswestry Disability Index; SF-36, 36-Item Short Form General Health 
Survey; MRI, magnetic resonance imaging; CFS, chronic fatigue syndrome; 
PTSD, post-traumatic stress disorder. 
as the absence of nerve root sedimentation in at least 1 trans-
verse MR image, at a level above or below, disregarding the 
location of the scan within the level and its proximity to the 
maximal stenosis”  ( Figure 1 ). As a result, the sign is defi ned 
as overall positive or negative for a given patient rather than 
level by level within a patient. 
 Statistical Analysis 
 Baseline characteristics of patients with and without a posi-
tive sedimentation sign were compared using a  χ 2 test for 
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 TABLE 2. (Continued) 
Characteristic
Sedimentation Sign
 P 
Negative 
(n  = 28)*
Positive 
(n  = 47)*
Additional surgical proce-
dures (2-yr rate), no. (%)§ 2 (7) 2 (4) 0.59
Additional surgical proce-
dures (3-yr rate), no. (%)§ 2 (7) 3 (6) 0.89
Additional surgical proce-
dures (4-yr rate), no. (%)§ 2 (7) 4 (9 0.84
 Recurrent stenosis/ 
 progressive listhesis 0 2 (5)
 Pseudarthrosis/fusion 
 exploration 0 0
 Complication or other 1¶ 0
 New condition 1¶ 1¶
 *Surgical information was available for 28 patients who had nonsedimenta-
tion sign and 47 patients who had sedimentation sign. Specifi c procedure 
information was available for 27 patients who had nonsedimentation sign 
and 44 patients who had sedimentation sign. 
 †None of the following were reported: aspiration, nerve root injury, vascular 
injury, other complication, and operation at wrong level. 
 ‡Any reported complications up to 8 wk after operation. None of the fol-
lowing were reported: bone graft complication, CSF leak, nerve root injury, 
paralysis, cauda equina injury, pseudarthrosis, wound infection, and wound 
dehiscence. 
 §One-, 2-, 3-, and 4-yr postsurgical reoperation rates are Kaplan Meier esti-
mates. Numbers and percentages are based on the fi rst additional surgery if 
more than 1 additional surgery. Surgical procedures include any additional 
spine surgery not just reoperation at the same level. 
 ¶Not estimable. 
 CSF indicates cerebrospinal fl uid; SD, standard deviation. 
 TABLE 2.  Operative Treatments, Complications 
and Events, According to Whether the 
Patient Had Foraminal Stenosis 
Characteristic
Sedimentation Sign
 P 
Negative 
(n  = 28)*
Positive 
(n  = 47)*
Procedure 0.67
 Decompression only 24 (89) 41 (93)
 Noninstrumented fusion 0 (0) 0 (0)
 Instrumented fusion 3 (11) 3 (7)
Multilevel fusion 1 (4) 3 (6) 1
Decompression level, no. (%)
 L2–L3 5 (19) 24 (51) 0.012
 L3–L4 17 (65) 39 (83) 0.15
 L4–L5 24 (92) 45 (96) 0.61
 L5–S1 14 (54) 16 (34) 0.14
Levels decompressed, no. (%) 0.026
 None 2 (7) 0 (0)
 1 4 (14) 8 (17)
 2 13 (46) 11 (23)
 3 + 9 (32) 28 (60)
Operation time, min, mean 
(SD)
137.4 
(88.1)
151.5 
(73.5) 0.46
Blood loss, mL, mean (SD) 480.3 (1001.3)
386.6 
(419.8) 0.58
Blood replacement, no. (%)
 Intraoperative replacement 3 (11) 6 (13) 1
 Postoperative transfusion 2 (7) 3 (7) 1
Length of hospital stay, d, 
mean (SD) 3.4 (2.3) 3.2 (1.7) 0.65
Intraoperative complications, no. (%)†
 Dural tear/spinal fl uid leak 2 (7) 5 (11) 0.71
 None 26 (93) 42 (89) 0.71
Postoperative complications/events, no. (%)‡
 Wound hematoma 1 (4) 0 (0) 0.38
 Other 1 (4) 3 (7) 1
 None 25 (89) 40 (87) 1
Postoperative mortality (death 
within 6 wk of surgery), 
no. (%)
0 (0) 0 (0)
Postoperative mortality (death 
within 3 mo of surgery), 
no. (%)
0 (0) 0 (0)
Additional surgical proce-
dures (1-yr rate), no. (%)§ 1 (4) 0 (0) 0.195
symptom severity or treatment outcome. This study evalu-
ated the association between the recently described sedimen-
tation sign and treatment outcomes in a cohort of patients 
enrolled in SPORT with LSS. We found that in these patients, 
a positive sedimentation sign was more often associated with 
central stenosis, multilevel stenosis, more proximal stenoses, 
and more severe degrees of canal narrowing; however, after 
adjusting for these traditional measures of stensosis severity 
along with demographic factors, we found that the group 
with a positive sedimentation sign displayed a somewhat 
greater surgical treatment effect for ODI. Thus, the sedimen-
tation sign may be a useful adjunct for physicians and patients 
in making informed treatment choices for LSS. Although both 
subgroups showed a positive treatment effect from surgery, 
those with a positive sedimentation sign showed a margin-
ally increased benefi t from surgery that was signifi cant for the 
ODI, although not signifi cantly different for general pain or 
physical function; thus the presence or absence of the sedi-
mentation sign could potentially help sway the balance of 
risks and benefi ts in patients who are uncertain about their 
preferred treatment choice. ( Continued )
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 Several studies have evaluated MRI characteristics that 
may be associated with LSS severity and treatment effect, 
most notably, the dural sac cross-sectional area. However, 
these studies failed to fi nd a signifi cant relationship between 
anatomical narrowing, clinical severity, and treatment 
effect.  5,7,8,11,15,18,19,22  Earlier studies revealed not only a wide 
range of results for both surgical and nonoperative interven-
tions, but also failed to fi nd a signifi cant predictive character-
istic. For example, Amundsen  et al 5 , 6 conducted a prospective 
study evaluating the imaging characteristics associated with 
LSS and found no correlation between the degree of dural sac 
narrowing and clinical disability or treatment effect. 
 Several other fi ndings of our study are consistent with prior 
studies. A positive sedimentation sign was strongly associated 
with central stenosis, whereas the negative sedimentation sign 
group was more likely to have only lateral recess or neurofo-
raminal stenosis; similarly, a positive sedimentation sign was 
associated with multiple stenotic levels (86%  vs . 46% in the 
negative sedimentation sign group,  P  = 0.01). 23 , 35 Because 
Barz  et al 23 only recently introduced the sedimentation sign, 
there are not many directly comparable studies that evaluated 
the association between the sedimentation sign and treatment 
outcomes. The observational study by Barz  et al 25 showed 
 TABLE 3.  Adjusted* As-Treated Time-Weighted Average 4-Year Outcomes and Treatment Effects 
According to Whether the Patient Had Nerve Root Sedimentation Sign 
Outcome
Nerve Root 
Sedimentation Sign
Surgical, 
Mean (SE)
Nonoperative, 
Mean (SE)
Treatment Effect† 
(95% CI)  P 
SF-36 bodily pain Negative sedimentation sign 26.3 (3.9) 14.8 (4.6) 11.5 (3.2–19.9) 0.007
(BP) (0–100)‡
Positive sedimentation sign 26.4 (3) 10.9 (3.1) 15.5 (9.1–21.8)  < 0.001
 P 0.98 0.50 0.44
SF-36 physical function Negative sedimentation sign 21.1 (4.1) 6 (4.7) 15.1 (6.9–23.3)  < 0.001
(PF) (0–100)‡
Positive sedimentation sign 21 (3.1) 3.3 (3.2) 17.7 (11.5–23.8)  < 0.001
 P 0.99 0.65 0.61
Oswestry Disability Index Negative sedimentation sign  − 16.2 (3)  − 9.1 (3.5)  − 7 ( − 13.3 to  − 0.8) 0.028
ODI (0–100)§
Positive sedimentation sign  − 20.4 (2.2)  − 4.4 (2.4)  − 16 ( − 20.8 to  − 11.1)  < 0.001
 P 0.28 0.28 0.023
Stenosis bothersomeness 
 index Negative sedimentation sign  − 6.1 (1)  − 2.9 (1.2)  − 3.2 ( − 5.6 to  − 0.8) 0.01
(0–24)¶
Positive sedimentation sign  − 7.5 (0.8)  − 1.9 (0.8)  − 5.7 ( − 7.6 to  − 3.7)  < 0.001
 P 0.25 0.49 0.094
 *Adjusted for age, sex, baseline outcome score, osteoporosis, L2–L3 stenosis level, L3–L4 stenosis level, central stenosis, and stenosis severity. 
 †Treatment effect is the difference between the surgical and nonoperative mean change from baseline. Analysis is done using a mixed model with a random sub-
ject intercept term. Treatment is a time-varying covariate where a patient’s experience prior to surgery is attributed to the nonoperative arm and time is measured 
from enrollment and his/her postsurgery outcomes are attributed to the surgical arm and time is measured from time of surgery. 
 ‡The SF-36 scores range from 0 to 100, with higher score indicating less severe symptoms. 
 §The ODI ranges from 0 to 100, with lower scores indicating less severe symptoms. 
 ¶The Stenosis bothersomeness index ranges from 0 to 24, with lower scores indicating less severe symptoms. 
 ODI indicates Oswestry Disability Index; SF-36, 36-Item Short Form General Health Survey; SE, standard error; PF, physical function; BP, body pain; CI, 
 confi dence level. 
that the sedimentation sign does not seem to predict surgical 
outcome, whereas in nonoperatively treated patients a posi-
tive sign was associated with a limited treatment outcome. 
 This study faced several limitations. This was a  post hoc 
subgroup analysis from the SPORT study and used an obser-
vational, as-treated analysis due to high levels of treatment 
crossover in the randomized groups.  However, we did use 
longitudinal mixed-models to attempt to control for con-
founding by any baseline differences between the subgroups. 
Furthermore, although excluded in the initial study by Barz 
 et al , 23 patients who had LSS at L5–S1 were included in this 
study. However, there were only 4 patients who had only 
single-level L5–S1 stenosis, and on further analysis, only 
one of these had a positive sedimentation sign. Although the 
treatment effect results were consistent for the main outcome 
measures, they were statistically signifi cant only for ODI and 
as such must be interpreted cautiously. It is worth noting, 
however, that the 2 measures (ODI and SBI) with the more 
suggestive fi ndings were condition-specifi c outcome measure, 
which may be more responsive than the more general SF-36 
measures. Also, because this was a subgroup analysis using 
previously collected and archived MRIs, our sample size and 
thus the power to detect a difference was somewhat limited. 
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We also cannot be sure that the subgroup for whom complete 
imaging was available is representative of the overall steno-
sis cohort; prior studies with this data, however, suggest that 
measure demographic and imaging characteristics were simi-
lar between the groups with and without archived imaging 
data. 27 Furthermore, we relied on clinically obtained images 
with varying image acquisition protocols, fi eld strength, slice 
orientation,  etc . This heterogeneity of imaging characteristics 
may have limited our ability to fully assess the association 
between sedimentation sign and treatment outcome. 
 This study employed an innovative approach by linking the 
assessment of a new diagnostic test with the evaluation of treat-
ment effects. This type of test evaluation has been referred to 
as “clinical test validation” 24 , 36 providing direct evidence about 
the clinical meaning of test results, which is far more relevant 
information for clinicians than measures of test accuracy alone 
( e.g ., test sensitivity and specifi city). SPORT offers a unique 
opportunity to evaluate emerging radiological tests, because 
the archived MR images can be revisited when new radiologi-
cal criteria like the sedimentation sign are discovered. It would 
be desirable if establishing trial-based digital archives of imag-
ing data became standard practice in the conduct of treatment 
trials to enable test evaluations such as the one presented here. 
 CONCLUSION 
 In this preliminary study, we demonstrated that controlling 
for other demographic and imaging features, a positive sedi-
mentation sign was associated with a somewhat greater sur-
gical treatment effect in patients with symptomatic LSS for 
ODI, though not for other measured outcomes. These fi nd-
ings suggest that a positive sedimentation sign may be use-
ful as an adjunct to help guide an informed treatment choice 
regarding surgery for patients with symptomatic LSS. The 
presence or absence of the sedimentation sign, which seems to 
help predict the size of the surgical treatment after adjusting 
for other traditional measures of stenosis severity, may help 
sway the balance of risks and benefi ts in patients who are 
uncertain about their preferred treatment choice. 
 ➢  Key Points 
 ?  LSS is one of the most common reasons for sur-
gery in the US elderly, but there is a dearth of reli-
able diagnostic tools that give a clear  indication 
for surgery. 
 ?  T2-weighted images of patients with LSS enrolled 
in SPORT were analyzed by an independent 
orthopedic surgeon for sedimentation sign. 
 ?  Also, 66% of the 115 patients whose images were 
analyzed were found to have a positive sedimen-
tation sign. 
 ?  Surgical treatment eﬀ ects for those patients 
with positive sedimentation sign were somewhat 
larger in all outcomes, and signifi cant for ODI 
( − 16  vs .  − 7;  P  = 0.02), after adjusting for other 
demographic and imaging features. 
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